An exercise related increase in ventricular rate in patients with permanent pacemakers has been clearly shown to improve exercise tolerance in nearly all ambulant patients undergoing pacemaker implantation.'-' There is still controversy about whether the maintenance of atrioventricular synchrony is important, with many studies showing little difference in exercise tolerance or haemodynamic variables with DDD or VVIR pacing.3-5 Atrioventricular synchrony is probably more important at rest than during exercise and most patients seem to prefer DDD pacing to VVIR pacing. 56 The superiority of the normal sinus node over artificial sensors, however, makes DDD pacing a better rate responsive system than VVIR pacing in most patients.
The sinus node as sensor The normal sinus node is the ideal physiological sensor but there are problems associated with using atrial sensing to determine ventricular rate. These include abnormal sinus node function, atrial arrhythmias, and the practical aspects of atrial sensing. The sinus node may be abnonnal because of chronotropic incompetence or may be denervated in the transplanted heart. Atrial arrhythmias will trigger inappropriate ventricular responses and abolish any useful rate response. An atrial lead is required in patients with atrioventricular nodal disease and some extra expertise and costs are needed for implantation and follow up of DDD pacemakers.
Artificial sensors Sensor driven rate responsive pacing is still clearly indicated those patients with moderate or severe chronotropic incompetence or atrial arrhythmias. Patients with the sick sinus syndrome and chronotropic incompetence will still require atrial pacing, either with AAIR or DDDR pacemakers, because this will reduce the incidence of atrial fibrillation, systemic emboli, and left ventricular failure.7 Patients with chronic atrial fibrillation are best treated with VVIR pacemakers.
The patient with intermittent atrial arrhythmias may be best treated with a mode switching DDDR pacemaker. These pacemakers will switch to VDIR either by sensing very Dual (or multiple) artificial sensors at present merely seem to be the sum of their imperfect parts, and they increase the size, cost, and current drain of the pacing unit. In patients with either chronotropic incompetence or mode switching DDDR pacemakers the best dual sensor system is the normal sinus node and an artificial sensor. [8] [9] [10] So where does this leave sensor driven, rate responsive pacing? There have been no major advances in sensors and therefore operators should continue to use the sensor with which they feel comfortable. Ambulant patients with chronotropic incompetence should have AAIR or DDDR pacemakers, and those with chronic atrial tachycardias should have VVIR pacemakers. In patients with intermittent atrial arrhythmias, the atrium should still be paced and sensed. This will probably reduce the occurrence of chronic atrial fibrillation and systemic emboli, as has been repeatedly shown in the sick sinus syndrome. Ideally in these patients the capabilities of sensor driven rate response and mode switching should be included to optimise pacing during intermittent or chronic atrial arrhythmias. Should patients with normal sinus nodes and atrioventricular block be given DDDR pacemakers with these capabilities? Up to 10% of these patients with atrioventricular block will go on to chronic atrial fibrillation or have intermittent atrial arrhythmias.14 This then becomes a question of cost. If a DDDR pacemaker costs much more than a DDD pacemaker (as it does in the United Kingdom) the answer is no. If the prices of both types are similar (as in the USA) then it is sensible to give the patient all the options with a DDDR pacemaker.
In conclusion, atrial sensing is the best rate responsive system for patients with normal sinus node function. Sensor driven rate response is important for patients with chronotropic incompetence or chronic atrial tachycardias. Patients with intermittent atrial tachycardias may have the best of both worlds from a mode switching DDDR/VDIR pacemaker, and this in conjunction with atrioventricular junctional ablation may be the best treatment for patients with drug resistant paroxysmal atrial fibrillation.
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